baber/WOPTO huggingface dataset:
Patent AU-2014287427-B2 (AU)
Title: Compositions and methods for treating neuropsychiatric disorders using an endothelin-B receptor agonist
Inventor: GULATI ANIL
IPC: A61P25/00
Filed: 2014-07-08
Granted: 2019-11-21
Abstract: The present invention relates to compositions and methods for treating neuropsychiatric disorders in vertebrates and humans. More specifically, the present invention provides for use of IRL-1620, an endothelin-B receptor agonist, in appropriate doses to be a neuroprotective and a neuroregenerative agent. Accordingly, in one aspect the disclosure provides a method of treating a neuropsychiatric disorder comprising administering to a patient in need thereof a therapeutically effective amount of an endothelin-B receptor agonist to treat the neuropsychiatric disorder. In some embodiments, the endothelin-B receptor agonist is co-administered with an additional agent to treat the neuropsychiatric disorder. In some embodiments, the additional agent is selected from the group consisting of an antidepressant, an anti-inflammatory agent, a CNS stimulant, a neuroleptic, and an anti-proliferative agent.
Patent AU-2014302227-B2 (AU)
Title: Downhole-adjusting impact apparatus and methods
Inventor: HRADECKY JASON ALLEN
IPC: E21B47/12
Filed: 2014-06-26
Granted: 2018-05-17
Abstract: A downhole-adjusting impact apparatus (DAIA) mechanically coupled between opposing first and second portions of a tool string, wherein: the tool string is conveyable within a wellbore extending between a wellsite surface and a subterranean formation; the first tool string portion comprises a first electrical conductor in electrical communication with surface equipment disposed at the wellsite surface; the DAIA comprises a second electrical conductor in electrical communication with the first electrical conductor; and the DAIA is operable to: detect an electrical characteristic of the second electrical conductor; impart a first impact force on the second tool string portion when the electrical characteristic is detected; and impart a second impact force on the second tool string portion when the electrical characteristic is not detected, wherein the second impact force is substantially greater than the first impact force.
Patent AU-2014351577-B2 (AU)
Title: Energy conversion device
Inventor: JUHASZNE MOLNAR MARIANNA
IPC: A61N1/16
Filed: 2014-11-17
Granted: 2019-02-21
Abstract: The present invention relates to energy conversion device. The characteristic features of the invention are that the cable (20) connecting the collection unit (10) and the conversion unit (30) to each other is made from a metal alloy containing a maximum of 0.7 mass% gold, a maximum of 0.7 mass% silver, between 2-8 mass% iron and at least 90 mass% bronze components, and the cable (20) has at least two bending zones (23), where the normal (21a) to the initial section (21) of the cable (20) entering the bending zone (23) and the normal (22a) to the exit section (22) of the cable (20) leaving the bending zone (23) are at an angle (a) of at least 10° to each other, the organic component of the charge (40) contains a maximum of 50 v/v% regenerating type microorganism group, while the inorganic component of the charge (40) contains at least 5 v/v% of a gold-bronze powder mixture, the condenser part-unit (32) is connected to an earth cable (50), and when the device is in its use position the first armoured plate (32a) of the condenser part- unit (32) is connected to the electrically conducting body (1) belonging to the environment via the earth cable (50) when the energy conversion device is in its use position, and the second armoured plate (32a') of the condenser part-unit (32), beside the cable (20), is in an electrically conducting connection with the charge (40).
Patent AU-2014369152-B2 (AU)
Title: System for the preparation of beverages
Inventor: CABILLI ALBERTO
IPC: A47J31/36
Filed: 2014-12-17
Granted: 2019-08-29
Abstract: The system comprises capsules (C) with a cup-shaped body (1) having an annular lateral wall (6) which tapers from a mouth opening (2) towards a bottom wall (5). These capsules (C) are of at least a first type and a second type, and have identical bottom walls (5) and different axial lengths (hi, h2, h3). The system further comprises an infusion assembly (10) wherein there is defined a variable-volume infusion chamber (20), having an introduction opening (20a), an end delimitation part (16a) having a shape corresponding to that of the bottom wall (5) of the capsules (C), and with a lateral delimitation structure (13a, 13b; 14) which comprises a static portion (13a, 13b) and which extends between said introduction opening (20a) and the end delimitation part (16a). The latter is movable away from the introduction opening (20a). The arrangement is such that a capsule (C) introduced into the infusion chamber (20) causes a movement of the end delimitation part (16a) away from the introduction opening (20a), such that the infusion chamber (20) assumes a configuration and dimensions corresponding to those of the type of capsule (C) introduced thereinto. The lateral delimitation structure (13a, 13b; 14) of the infusion chamber (20) comprises further a movable portion (14) cooperating with the static portion (13a, 13b), and movable transversely to the direction of introduction of the capsules (C) into the chamber (20), against the action of an opposing spring (15), so as to increase the cross-section of the introduction opening (20a) and, correspondingly, the volume of the infusion chamber (20).
Patent AU-2014374057-B2 (AU)
Title: Plants with enhanced photosynthesis and methods of manufacture thereof
Inventor: SCHNELL DANNY J
IPC: C12N15/82
Filed: 2014-12-24
Granted: 2020-08-27
Abstract: A transgenic plant having enhanced photosynthesis is disclosed. The transgenic plant is transformed with a transgenic polynucleotide encoding a heterologous bicarbonate transporter. The bicarbonate transporter can be from an algae or a cyanobacterial species. The transgenic polynucleotide comprises a nucleic acid sequence encoding the bicarbonate transporter under the control of a functional plant promoter and optionally includes a chloroplast envelope targeting peptide heterologous to the bicarbonate transporter. Methods of making the transgenic plant and transgenic polynucleotide are disclosed.
Patent AU-2014395122-B2 (AU)
Title: Improving well survey performance
Inventor: HOLMES ANNE
IPC: G01V3/18
Filed: 2014-07-31
Granted: 2017-12-14
Abstract: In some aspects, techniques and systems for improving a well survey are described. An error analysis is performed to identify errors associated with operating a well survey instrument in a magnetic environment at a wellbore location. Based on the error analysis, an instrument performance model (IPM) is selected for a well survey by the well survey instrument. In some cases, the IPM is selected such that the errors satisfy specifications of the IPM.
Patent AU-2014407165-B2 (AU)
Title: Well construction real-time telemetry system
Inventor: BROWN-KERR WILLIAM
IPC: E21B47/18
Filed: 2014-09-23
Granted: 2018-03-08
Abstract: Downhole assemblies including a plurality of tubular members extendable within a wellbore and defining a through bore. A telemetry device is positioned within a wall of one of the plurality of tubular members and has a secondary flow path defined therethrough and a valve element engageable with a valve seat provided at an upper end of the secondary flow path. The secondary flow path extends between an inlet and an outlet, both of which fluidly communicate with the through bore and are defined in the one of the plurality of tubular members. A flow restrictor is located within the through bore and is axially positioned between the inlet and the outlet of the secondary flow path. The valve element is actuatable to control fluid flow through the secondary flow path to selectively generate a fluid pressure pulse.
Patent AU-2015204304-B2 (AU)
Title: Viral Inactivation Using Improved Solvent-Detergent Method
Inventor: FELGENHAUER MARTIN
IPC: A61L2/00
Filed: 2015-07-14
Granted: 2016-04-07
Abstract: The present specification discloses methods of inactivating a lipid-coat containing virus and proteins essentially free of a lipid-coat containing virus obtained from such methods.
Patent AU-2015208884-B2 (AU)
Title: Improvements in the synthesis of phycocyanins
Inventor: BRAIN CHELSEA MARIE
IPC: A61K8/30
Filed: 2015-01-27
Granted: 2019-07-04
Abstract: The invention discloses microorganism cell culture conditions that result in increased cellular and media concentrations of a biological pigment. The invention has applications in use as a natural food colouring, as antioxidants in the food supplement industries, in the nutraceutical, pharmaceutical, and cosmeceutical industries, and a non-toxic ink. The method results in pigment that is relatively easy to separate from the microorganism culture.
Patent AU-2015234295-B2 (AU)
Title: Assay apparatuses, consumables and methods
Inventor: CHAMBERLIN IAN
IPC: G01N1/28
Filed: 2015-09-29
Granted: 2017-08-03
Abstract: An apparatus for conducting a measurement in a multi-well assay test plate is described. The apparatus includes a subassembly capable of supporting and translating the test plate to one or more components of the apparatus. An auxiliary plate subassembly is also included that has a plurality of auxiliary wells comprising dry assay reagents for use in an assay with the test plate.
Patent AU-2015243881-B2 (AU)
Title: Selective advantage in fermentation
Inventor: GREENHAGEN EMILY H
IPC: C12N1/21
Filed: 2015-04-08
Granted: 2021-08-19
Abstract: Disclosed are transformed cells and related nucleotide and protein sequences, and fermentation compositions and methods, all of which are related to providing selective advantage in fermentation. For example, a selective advantage results from transformation of a cell with a nucleic acid that allows a transformed cell to metabolize one or more nitrogen-, phosphorous-, and/or sulfur-containing compounds that a native cell of the same species as the transformed cell cannot metabolize, and from fermentation of the transformed cell using one or more feedstocks, such as fractioned grain, which are depleted in or free of conventional nitrogen-, phosphorous-, and/or sulfur-containing compounds that a native cell of the same species as the transformed cell can metabolize. Also disclosed are methods for improved oxygen transfer in an aerobic or microaerobic fermentation.
Patent AU-2015253372-B2 (AU)
Title: Systems and methods for processing event timing images
Inventor: ALDRIDGE JEREMY W
IPC: H04N5/232
Filed: 2015-04-28
Granted: 2018-07-19
Abstract: A system for processing event timing images includes: area scan image sensor for generating sequential digital two-dimensional images of a scene; and time delay integration module for processing the sequential digital two-dimensional images to generate a time delay integration image of a moving object in the scene.
Patent AU-2015264895-B2 (AU)
Title: Substituted Acylanilides and Methods of Use Thereof
Inventor: DALTON JAMES
IPC: C07C275/40
Filed: 2015-12-03
Granted: 2017-06-29
Abstract: This invention provides substituted acylanilide compounds and uses thereof in treating a variety of diseases or conditions in a subject, including, inter alia, a muscle wasting disease and/or disorder or a bone-related disease and/or disorder.
Patent AU-2015273564-B2 (AU)
Title: Vehicle control system and method
Inventor: HEMES ELLIOT
IPC: B60W10/20
Filed: 2015-06-10
Granted: 2018-11-08
Abstract: Some embodiments of the present invention provide a motor vehicle control system for controlling a plurality of vehicle subsystems to operate in a plurality of subsystem control modes in dependence on a driving surface. The system is operable in an automatic control mode selection condition in which the system is configured to determine said driving surface automatically and to cause each of the plurality of vehicle subsystems to operate in a predetermined one of said plurality of subsystem control modes in dependence on the determined driving surface. The system may be configured to determine if an interruption in powertrain torque occurs and to, in dependence on the identification of a powertrain torque interruption event, temporarily suspend causing an automatic change to said predetermined one of said plurality of subsystem control modes in which each subsystem is operating..
Patent AU-2015277000-B2 (AU)
Title: Efficient methods for authenticated communication
Inventor: LE SAINT ERIC
IPC: H04L9/14
Filed: 2015-06-18
Granted: 2019-05-16
Abstract: Embodiments of the invention relate to efficient methods for authenticated communication. In one embodiment, a first computing device can generate an ephemeral key pair comprising an ephemeral public key and an ephemeral private key. The first computing device can generate a first shared secret using the ephemeral private key and a static second device public key. The first computing device can encrypt request data using the first shared secret to obtain encrypted request data. The first computing device can send a request message including the encrvpted request data, and the ephemeral public key to a server computer. Upon receiving a response message from the server computer, the first computing device can determine a second shared secret using the ephemeral private key and the blinded static second device public key. The first computing device can then decrypt the encrypted response data from the response message to obtain response data.
Patent AU-2015279560-B2 (AU)
Title: Dual PDGF/VEGF antagonists
Inventor: MOSYAK LIDIA
IPC: C07K16/22
Filed: 2015-06-28
Granted: 2020-09-17
Abstract: The invention provides a dual VEGF/PDGF antagonist comprising a VEGF antagonist linked to a PDGF antagonist. The VEGF antagonist is an antibody to a VEGF or VEGFR or is a VEGFR extracellular trap segment (i.e., a segment from the extracellular region of one or more VEGFR receptors that inhibits binding of at least one VEGFR to at least one VEGF). The PDGF antagonist is an antibody to a PDGF or PDGFR or is a PDGFR extracellular trap segment (i.e., segment from the extracellular region of one or more PDGFRs, which inhibits binding of at least one PDGFR and at least one PDGF). The dual antagonist is preferably conjugated to a half-life extending moiety, such as a HEMA-PC polymer. The dual antagonist is particularly useful for treating wet aged related macular degeneration.
Patent AU-2015302412-B2 (AU)
Title: Deposition of clay structures
Inventor: VAN DER HORST ARJEN
IPC: C04B28/00
Filed: 2015-08-13
Granted: 2020-02-27
Abstract: A method of printing includes mixing a clay mixture with an alkaline agent to form a printable mixture; forming pellets from the printable mixture; ejecting the pellets from a print head onto a printing surface; and curing the pellets.
Patent AU-2015316970-B2 (AU)
Title: Polymer composition for a layer of a layer element
Inventor: ODERKERK JEROEN
IPC: H01L31/048
Filed: 2015-09-15
Granted: 2018-01-18
Abstract: The present invention relates to a polymer composition, to a layer element, preferably to at least one layer element of a photovoltaic module, comprising the polymer composition and to an article which is preferably said at least one layer of a layer element, preferably of a layer element of a photovoltaic module.
Patent AU-2015324163-B2 (AU)
Title: Sphingosine-1-phospate receptor modulators for treatment of cardiopulmonary disorders
Inventor: ROBERTS EDWARD
IPC: C07C255/63
Filed: 2015-09-28
Granted: 2020-06-25
Abstract: The invention provides compounds effective as sphingosine-1 -phosphate receptor modulators for treatment of cardiopulmonary diseases, such as hypertension (including malignant hypertension), angina, myocardial infarction, cardiac arrhythmias, congestive heart failure, coronary heart disease, atherosclerosis, angina pectoris, dysrhythmias, cardiomyothopy (including hypertropic cardiomyothopy), heart failure, cardiac arrest, bronchitis, asthma, chronic obstructive pulmonary disease, cystic fibrosis, croup, emphysema, pleurisy, pulmonary fibrosis, pneumonia, pulmonary embolus, pulmonary hypertension, mesothelioma, ventricular conduction abnormalities, complete heart block, adult respiratory distress syndrome, sepsis syndrome, idiopathic pulmonary fibrosis, scleroderma, systemic sclerosis, retroperitoneal fibrosis, prevention of keloid formation, or cirrhosis.
Patent AU-2015325743-B2 (AU)
Title: Method for manufacturing ashless coal
Inventor: SAKAI KOJI
IPC: C10L5/00
Filed: 2015-09-17
Granted: 2018-06-21
Abstract: The present invention is provided with a step for preheating coal, a step for heating an extraction solvent, a step for mixing the preheated coal and the extraction solvent heated to a higher temperature than the preheated coal and thereby heating the coal, a step for separating a solution in which a coal component is dissolved from the mixture of the coal and the extraction solvent, and a step for evaporating and separating the extraction solvent from the solution.
Patent AU-2015342237-B2 (AU)
Title: Drilling ram device
Inventor: PUTTMANN FRANZ-JOSEF
IPC: E21B4/06
Filed: 2015-11-04
Granted: 2018-08-23
Abstract: The invention relates to a drilling ram device for drilling into the soil, which comprises at least a housing section for an impact piston, characterized in that an annular insert is arranged in front of the impact piston in the housing such that it transmits at least part of the energy of the impact piston to the housing, and that the annular insert is held by means of a shrinkage connection.
Patent AU-2015394224-B2 (AU)
Title: Tibial support of artificial knee joint
Inventor: ZHU JACK
IPC: A61F2/38
Filed: 2015-10-28
Granted: 2018-10-18
Abstract: A tibial support of an artificial knee joint, comprising a main tibial support body (100) and a tibial support platform (200), wherein the main tibial support body (100) is wing-shaped, a central axis thereof being vertical to the tibial support platform (200). A plurality of hollow screw holes is provided at the upper part of the main body (100). The tibial support platform (200) is located above the main tibial support body (100). The surface of the tibial support platform (200) is an organic polymer material layer matching a tibial liner. The hollow screw holes in the tibial support are sealed by the polymer material layer. Because a tibial support of an artificial knee joint adopts a high-biocompatibility organic polymer material, physical machining is allowed in an operation, and meanwhile, the surface corrosion of the tibial support is reduced. Hollow screw holes are sealed by means of a polymer material layer, thereby inhibiting joint liquid from entering the holes, and reducing the transportation of particles. Recesses (201) are provided at positions, corresponding to the screw holes, on the polymer surface, thereby aiding in drilling holes and mounting screws in an operation.
Patent AU-2015414494-B2 (AU)
Title: Medium voltage transformerless multilevel converter and method for controlling a medium voltage transformerless multilevel converter
Inventor: MIHALACHE LIVIU
IPC: H02M7/483
Filed: 2015-11-13
Granted: 2019-04-18
Abstract: A multilevel converter includes single phase configurations. A single phase configuration has a first half-bridge (HB) module, a second HB module separated by a first capacitor coupled to a DC link, and a neutral point clamped (NPC) module clamped to the first HB module and the second HB module. Further, the single phase configuration has a first individual switching device and a second individual switching device, the first individual switching device operably connected to the first HB module and the NPC module, and the second individual switching device operably connected to the second HB module and the NPC module. The converter further includes a power output assembly comprising multiple phases and providing multiple-phase alternating (AC) power, wherein the single phase configuration supplies power to one of the multiple phases of the power output assembly.
Patent AU-2016200886-B2 (AU)
Title: Apparatus and method for evaluating equipment operation in a demand coordination network
Inventor: WILLIG RANDY C
IPC: H04L29/08
Filed: 2016-02-11
Granted: 2016-12-22
Abstract: An apparatus, including a plurality of devices, a network operations center (NOC), and a plurality of control nodes. Each device consumes a portion of the resource when turned on, and performs a corresponding function within an acceptable operational margin by cycling on and off. The NOC generates a plurality of run time schedules that coordinates run times for the each of the plurality of devices to control the peak demand of the resource. Each of the control nodes is coupled to a corresponding one of the devices. The plurality of control nodes transmits sensor data and device status to the NOC for generation of the plurality of run time schedules, and executes selected ones of the run time schedules to cycle the plurality of devices on and off, and each control node monitors a corresponding device for deviations from nominal operation. (FIG. 13) CONTROL NODE FOR FACILITY/DEVICE PERFORMANCE MONITORING 1300 1303 NODE RUN CTRL DSB PROCESSOR R 1304 DCN & INM DON 1311 SENSEDATA 11 __r-1316 LOCAL LMFB GLOBAL GLOBAL LOCAL AOEL S 1 AODES GRRE SCHEDULE LRRE SCHEDULE MODULE LME MODULE 1307 1308 1305 1306--
Patent AU-2016202731-B2 (AU)
Title: Immune-modulating agents and uses therefor
Inventor: DONNELLY SHEILA
IPC: A61K38/17
Filed: 2016-04-28
Granted: 2018-10-25
Abstract: H:\seh\Intrwovn\NRPortbl\DCC\SEH\10055433_1.docx-28/04/2016 Abstract This invention discloses the use of Heminth Defense Molecules in methods and compositions for modulating immune responses including treating or preventing undesirable or deleterious immune responses.
Patent AU-2016203598-B2 (AU)
Title: Systems and methods for maintaining a narrow body lumen
Inventor: SARNA SURBHI
IPC: A61B1/00
Filed: 2016-05-31
Granted: 2018-03-15
Abstract: Abstract A narrow body lumen diagnostic device (100), comprising a guide wire (334) capable of providing light or sensing an image and for guiding a catheter to a target location, said guide wire (334) including illuminating fibers (332) or imaging fibers (308); and a catheter including imaging fibers (308) if said guide wire (334) includes illuminating fibers (332) or said catheter including illuminating fibers (332) if said guide wire (334) includes imaging fibers (308).
Patent AU-2016209516-B2 (AU)
Title: Extruded protein product and methods of making
Inventor: WALTHER GOERAN
IPC: A23J1/14
Filed: 2016-01-19
Granted: 2020-04-30
Abstract: The present disclosure relates to extruded protein products and methods for producing an extruded protein product. In particular, an extruded piece is disclosed having a high protein content and having a desirable texture and flavor. Methods for making an extruded piece include processing, under extrusion conditions, a combination of a powdered protein ingredient, a protein matrix disruptive ingredient, water, and an oil.
Patent AU-2016233511-B2 (AU)
Title: Transport of natural gas through solution in liquid hydrocarbon at ambient temperature
Inventor: VOELKER JOSEPH J
IPC: C10L3/06
Filed: 2016-03-11
Granted: 2018-12-20
Abstract: A method of transporting natural gas by liquefaction of natural gas at ambient temperature, achieved by mixing the natural gas at high pressure with a hydrocarbon that is a stable liquid at ambient temperature and ambient pressure. The hydrocarbon liquid may be crude oil or a distillate of crude oil. The method includes: liquefaction: mixing the natural gas with the hydrocarbon liquid at an ambient temperature and a high pressure to generate a liquid mixture, which contains the natural gas dissolved in the hydrocarbon liquid; shipping: transporting the liquid mixture using a marine tanker, during which the liquid mixture is maintained at ambient temperature and the high pressure; and regasification: at the destination, releasing a gas from the liquid mixture by lowering the pressure of the liquid mixture. The hydrocarbon liquid may be used multiple times.